Cancer Weekly articles from January 2002

Cancer Weekly archives from January 2002

Controlled Transfer Of FADD Gene Kills Glioma, Leaves Other Cells Intact.(Brief Article)
January 1, 2002... 2001 DEC 25 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - New York's Mt. Sinai medical researchers may have found a better way to treat glioma with gene therapy while at the same time sparing normal brain tissues. ...

Antigen Construct, Cytokine Combo Treats and Prevents Male Malignancies.(Brief Article)
January 1, 2002... 2001 DEC 25 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - University of Iowa researchers have developed recombinant therapies that can treat and prevent prostate cancer tumors in mice. According to a contingent...

Breast Fluid May Mean Cancer Risk.(Brief Article)
January 1, 2002... 2001 DEC 25 - (NewsRx.com & NewsRx.net) -- Researchers who studied specimens from thousands of women suggest that the presence of abnormal cells in breast fluid may predict a doubled risk of breast cancer. In a study appearing December 5,...

Study Shows Letrozole Shrinks Tumors Better Than Tamoxifen.(Brief Article)
January 1, 2002... 2001 DEC 25 - (NewsRx.com & NewsRx.net) -- A new cancer drug called letrozole (trade name Femara) worked better at shrinking breast cancer tumors than did the front-line breast cancer drug tamoxifen among a group of postmenopausal women with...

Two-Step Approach For Myeloma Shows Promise.(Brief Article)
January 1, 2002... 2001 DEC 25 - (NewsRx.com & NewsRx.net) -- Using a tag-team approach, researchers believe they may be able to increase survival for patients with multiple myeloma. In a multicenter study led by Dr. David Maloney at the Fred Hutchinson...

Cytokine Blocking Advances Angiogenesis, Progression In Murine Liver Cancer.(Brief Article)
January 1, 2002... 2001 DEC 25 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A new study of liver cancer pathogenesis has shown angiogenesis and liver malignancy can be induced by blocking transforming growth factor-beta (TGF-(beta))...

High-Dose Chemotherapy Causes Post-Transplant Osteoporosis.(Brief Article)
January 1, 2002... 2001 DEC 25 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Intensive chemotherapy causes bone degradation sometimes seen after stem cell transplantation, researchers in Genova, Italy report. "Osteoporosis is a...

Natural Killer Cell-Enhancing Cytokines Reduce Residual Disease.(Brief Article)
January 1, 2002... 2001 DEC 25 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Cytokines that stimulate natural killer (NK) cell activity may help control residual malignancy after stem cell transplantation, researchers in Minnesota...

Cancer Patients Face Too Many Barriers For Care, Panel Says.(Brief Article)
January 1, 2002... 2001 DEC 25 - (NewsRx.com & NewsRx.net) -- The United State's health care system is failing cancer patients, who often find themselves battling the system in addition to their disease, a presidential commission contends. "For people who...

Phase IIb Clinical Trial For Squalamine Initiated In Lung Cancer Patients.(Brief Article)
January 1, 2002... 2001 DEC 25 - (NewsRx.com & NewsRx.net) -- Genaera Corporation announced the commencement of a Phase IIb clinical trial designed to test squalamine, an angiogenesis inhibitor, for the treatment of patients with non-small cell lung cancer...

Texas Specialist Named New Head Of National Cancer Institute.(Brief Article)
January 1, 2002... 2001 DEC 25 - (NewsRx.com & NewsRx.net) -- Dr. Andrew von Eschenbach, a urologist at the University of Texas M.D. Anderson Cancer Center in Houston, Texas, has been named the new director of the National Cancer Institute, the White House...

Millennium In-Licenses Novel Target.(Brief Article)
January 1, 2002... 2001 DEC 25 - (NewsRx.com & NewsRx.net) -- Targeted Diagnostics and Therapeutics, Inc., (TDT) has granted Millennium Pharmaceuticals, Inc., license to TDT's intellectual property surrounding guanylyl cyclase C (GC-C), a protein uniquely...

CyDex Licenses Captisol System To OSI.(Brief Article)
January 1, 2002... 2001 DEC 25 - (NewsRx.com & NewsRx.net) -- CyDex, Inc., has signed an agreement with OSI Pharmaceuticals, Inc., (OSIP) licensing Captisol, the advanced formulation system from CyDex, as a drug delivery vehicle for promising compounds under...

Stomach Surgery Does Not Mean Greater Risk For Barrett Esophagus.(Brief Article)
January 1, 2002... 2001 DEC 25 - (NewsRx.com & NewsRx.net) -- A study in the December 2001 issue of the journal Gastroenterology shows patients who have undergone stomach surgery are not at higher risk for esophageal cancer. The results of this study dispute...

Survey Reveals That 7 Of 10 Men Are Not Aware Of Prostate Cancer.(Brief Article)
January 1, 2002... 2001 DEC 25 - (NewsRx.com & NewsRx.net) -- Men are generally more aware of lung or breast cancer than they are of prostate cancer, a new international survey reveals. The results of an NOP Healthcare survey conducted among 1400 people in 7...

Rituximab Plus CHOP Increases Survivability, New Study Says.(Brief Article)
January 1, 2002... 2001 DEC 25 - (NewsRx.com & NewsRx.net) -- Patients with an aggressive form of blood cancer, non-Hodgkin lymphoma, can increase their chance of a cure with the new drug combination MabThera (rituximab) plus CHOP (standard chemotherapy),...

Anticancer Mechanism of Green Tea Identified.(Brief Article)
January 1, 2002... 2001 DEC 25 - (NewsRx.com & NewsRx.net) -- Researchers at the University of South Florida's H. Lee Moffitt Cancer Center and Research Institute have identified one plausible reason for the well-documented but poorly understood anticancer effect...

CaP CURE and Acurian Help Patients Learn About Emerging Treatment Options.(Brief Article)
January 1, 2002... 2001 DEC 25 - (NewsRx.com & NewsRx.net) -- Acurian, which launches clinical trials for biopharmaceutical companies, has signed an agreement with CaP CURE, the world's largest private source of prostate cancer research funding. Under the...

Increased Screening May Not Be Medical Decision Driven.(Brief Article)
January 1, 2002... 2001 DEC 25 - (NewsRx.com & NewsRx.net) -- Doctors report increased use of prostate-specific antigen tests to screen for early stage prostate cancer, according to a new study. Although increased screening is generally seen as a good thing, in...

Investigational Contrast Agent Detects Lymph Node Disease.(Brief Article)
January 1, 2002... 2001 DEC 25 - (NewsRx.com & NewsRx.net) -- Cytogen Corporation and Advanced Magnetics, Inc., announced that Combidex, an investigational magnetic resonance imaging (MRI) contrast agent, is able to distinguish malignant from normal lymph nodes...

MediGene, AG, Submits Leuprogel To German Regulatory Authorities.(Brief Article)
January 1, 2002... 2001 DEC 25 - (NewsRx.com & NewsRx.net) -- Atrix Laboratories, Inc.'s, European marketing partner, MediGene, AG, has submitted a Marketing Authorization Application (MAA) for Leuprogel One-Month Depot, leuprolide acetate for the treatment of...

Minimally Invasive Therapy Eliminates Disease, Preserves Potency.(Brief Article)
January 1, 2002... 2001 DEC 25 - (NewsRx.com & NewsRx.net) -- Endocare, Inc., announced that all nine men who took part in a pilot study of a new nerve-sparing cryosurgery procedure to treat early stage prostate cancer were disease free, and seven remained...

Praecis Plans To Proceed With Development Of Plenaxis.(Brief Article)
January 1, 2002... 2001 DEC 25 - (NewsRx.com & NewsRx.net) -- Praecis Pharmaceuticals, Inc., (PRCS) has discussed with representatives from the U.S. Food and Drug Administration (FDA) its plans to advance the development of Plenaxis (abarelix for injectable...

Exelixis Delivers Additional Cancer Targets To Protein Design Labs.(Brief Article)
January 1, 2002... 2001 DEC 25 - (NewsRx.com & NewsRx.net) -- Exelixis, Inc., has delivered five additional cancer antibody targets to Protein Design Labs, Inc., (PDL) in the companies' ongoing oncology collaboration. The collaboration, signed in May 2001,...

Genzyme Molecular Oncology, Kirin Form Partnership To Develop Antibody Therapeutics.(Brief Article)
January 1, 2002... 2001 DEC 25 - (NewsRx.com & NewsRx.net) -- Genzyme Molecular Oncology and Kirin Brewery Co., Ltd., of Japan have formed a collaboration to develop and commercialize fully human monoclonal antibodies to be used as therapies in the areas of...

Some Cancer Patients May Benefit From A Less Aggressive Approach.(Brief Article)
January 1, 2002... 2001 DEC 25 - (NewsRx.com & NewsRx.net) -- Conventional wisdom over the past 30 years has developed a well-defined path for physicians who recommend stem cell transplants for their cancer patients - destroy the blood cell factory and the immune...

Boehringer Ingelheim And ImmunoGen Sign Exclusive License Agreement.(Brief Article)
January 1, 2002... 2001 DEC 25 - (NewsRx.com & NewsRx.net) -- Boehringer Ingelheim International GmbH and ImmunoGen, Inc., (IMGN) have agreed to collaborate on the development of a new product combining ImmunoGen's maytansinoid Tumor-Activated Prodrug (TAP)...

Wyeth-Ayerst Licenses Ludwig Institute Antibody.(Brief Article)
January 1, 2002... 2001 DEC 25 - (NewsRx.com & NewsRx.net) -- Wyeth-Ayerst Laboratories has entered into an exclusive option and license agreement with the Ludwig Institute for Cancer Research (LICR) for an anticancer therapy based on an LICR antibody. Under...

Second Stem Cell Transplant Effective After Relapse.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Acute leukemia patients who don't achieve a durable response to stem cell transplantation can benefit from a second transplant, researchers in Europe report....

New Inhibitor Arrests Growth, Induces Apoptosis To Regulate Cells.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Scientists now know the newly identified cytokine vascular endothelial growth inhibitor (VEGI) prevents cell proliferation by way of dual mechanisms. ...

Minimal Nutrition Might Control Some Prostate, Pancreatic Cancers.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- Until recently, radiation, drugs and surgery were the approaches accepted by the medical establishment to treat cancer. Diet has also been recommended but for strengthening the body - not for therapy....

Interferon Doesn't Affect Stem Cell Transplantation Outcome.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Chronic myelogenous leukemia (CML) patients treated with interferon-(alpha) remain suitable candidates for stem cell transplantation, researchers say. ...

Ridding Cells Of Heat Shock Protein 70 Enhances Tumor Immunogenicity.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Researchers in France may have discovered a better way to produce immunity against colon cancer cells, leading the way for the development of new tumor...

Testosterone Affects HBV-Related Hepatocellular Carcinoma Risk In Men.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A new Japanese study suggests sex hormones influence the formation of primary liver cancer, or hepatocellular carcinoma (HCC), in men infected with hepatitis B...

Tumor Size Does Not Reflect Cancer Severity.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- A fundamental assumption of lung cancer screening is that small tumors are less likely to have metastasized than large tumors. But a new study by researchers with Duke University's Department of...

Two New Mouse Models Of Human Lung Cancer Developed.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- Independent research groups from Memorial Sloan-Kettering Cancer Center and the Massachusetts Institute of Technology have developed mouse models of human lung cancer that shed new light on the...

High CXCR4 Expression Predicts Organ Involvement.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Europe say that they have found a strong prognostic marker for organ involvement in acute lymphoblastic leukemia patients. "Childhood acute...

Cyclosporine A Reduces Chemotherapy Resistance.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Texas have found a way to improve the efficacy of chemotherapy drugs used to treat high-risk acute myeloid leukemia (AML) patients. ...

Carnegie Corporation President Joins Cell Therapeutics Board.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- Vartan Gregorian, PhD, president of Carnegie Corp. of New York, has agreed to join the board of directors of Cell Therapeutics, Inc. (CTIC). Carnegie Corporation is the grant-making foundation created...

PhotoCure Obtains IND From The FDA for Hexvix.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has approved PhotoCure's Investigational New Drug application for its new photodiagnostic agent Hexvix. As a result, PhotoCure is now in a position to start...

Navelbine, Herceptin Combination Induces 78% Response Rate In Trials.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- Researchers investigating the combination of Navelbine (vinorelbine tartrate) Injection, a first-line chemotherapy treatment for advanced non-small cell lung cancer, and the monoclonal antibody therapy...

Protein Blocks Cell Proliferation In Breast Tissue.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- The discovery of a protein that blocks the proliferation of cells in breast tissue could be good news for future generations of breast cancer sufferers. During pregnancy, breast epithelial cells...

High-Dose Radiation Effective For Some Childhood Cancers.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- Directing high-level doses of radiation at malignant tumors during surgery shows promise in treating certain childhood cancers. Eleven of 13 children in an Ohio State University study remained...

High-Tech Movies Of Living Cells Show Effects Of Genetic Mutations.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- Using an imaging technique that records movies of microscopic processes inside living cells, scientists are learning new information about how mutations in certain genes cause cancer and how...

Persistent HPV Infections Linked To Greater Risk Of Cancerous Lesions.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- Persistent human papillomavirus (HPV) infection is associated with a much greater risk of developing squamous intraepithelial lesions (SILs, cancerous lesions between layers of tissues) in the cervix,...

Interferon-(alpha) With Cytarabine Effective For Early Treatment.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Spain say that the combination of interferon and a form of cytarabine can produce positive results in patients with newly diagnosed chronic...

Study Reveals Patients With Certain Colorectal Cancer Face Increased Risk of Developing Other Cancers.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- Patients with a particular type of colorectal cancer (carcinoids, which affect about 1% of colorectal cancer patients) have a significantly increased risk of developing other cancers, including...

DNA Diagnostic Technique Could Offer More Accurate Cancer Diagnosis.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- A DNA diagnostic technique developed by Lawrence Livermore National Laboratory scientists is expected to provide a valuable new tool to improve cancer diagnosis. The advance is described in a paper...

AAMC Issues New Guidelines On Financial Conflicts Of Interest.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- The Association of American Medical Colleges (AAMC) has released the first report of its Task Force on Conflicts of Interest in Clinical Research "Protecting Subjects, Preserving Trust, Promoting...

Phylogix Announces $2.95 Million Investment Through Biotechnology Value Fund.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- Phylogix, Inc., has completed a $2.95 million private placement of Series A preferred stock. The investment was led by the Biotechnology Value Fund, LP, of San Francisco and included the Small...

Zila Reports Fiscal 2002 First Quarter Results.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- Zila, Inc., (ZILA) reported revenue of $19,704,000 in the first quarter of fiscal year 2002 ended October 31, 2001, compared with revenue of $18,836,000 in the period a year ago. The net loss for the...

Genetic Mutation Linked To Breast, Ovarian Cancer Underestimated?(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- Mutations in key genes that could make some women more susceptible to breast and ovarian cancer may be more widespread than researchers had previously believed. These findings from a new...

Maximum Triapine Dose Studied In Advanced Disease.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- Vion Pharmaceuticals, Inc., announced the initiation of a second Phase I clinical trial of Triapine in patients with advanced chronic and acute leukemias who are no longer responding to standard...

Gliadel Wafer Provides Clinical Benefit With Acceptable Safety.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- Guilford Pharmaceuticals, Inc., announced in December (2001) that the Oncologic Drugs Advisory Committee (ODAC) voted 8 to 5 that Gliadel Wafer (polifeprosan 20 with carmustine implant) provides...

Revimid Demonstrates Antitumor Activity In Phase I/II Clinical Trials.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- Kenneth Anderson, MD, from the Dana-Farber Cancer Institute at Harvard University and Bart Barlogie, MD, PhD, from the Arkansas Cancer Research Center and their colleagues presented new clinical data at...

Radioimmunotherapy Produces Durable Responses.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- According to studies presented at the 43rd annual meeting of the American Society of Hematology, Bexxar (tositumomab and iodine I-131 tositumomab), an investigational radioimmunotherapy being studied...

Atrix Earns Milestone Payment For FDA Filing Of Leuprogel.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- Atrix Laboratories, Inc., (ATRX) has earned a $3 million milestone payment from Sanofi-Synthelabo for the filing of the New Drug Application (NDA) for Leuprogel Three-Month Depot, leuprolide acetate for...

Brachytherapy System Gets 510(k) Clearance.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- Imagyn Medical Technologies, Inc., has received 510(k) clearance from the U.S. Food and Drug Administration to sell isosleeve, a sterilized custom preloaded needle delivery system for prostate...

CPT Codes Issued By AMA For Radiofrequency Ablation Of Liver Tumors.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- The American Medical Association (AMA) has issued Current Procedural Terminology (CPT) codes for the radiofrequency (RF) ablation of liver tumors in the new 2002 edition of the AMA's CPT official coding...

Conforma Therapeutics Expands Cancer Collaborations With Duke Agreement.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- Conforma Therapeutics Corp. has entered into an exclusive licensing agreement and research collaboration with Duke University Medical Center. The new agreement with Duke consolidates Conforma's...

Latino Men Face Different Obstacles To Cancer Screening.(Brief Article)
January 8, 2002... 2002 JAN 8 - (NewsRx.com & NewsRx.net) -- Nearly half of Latino men have never had a recommended digital rectal exam to check for prostate and colorectal cancer, but the barriers to cancer screenings differ across subgroups of Cuban Americans,...

Chemotherapy, Tamoxifen Treatment Can Impair Physical Function Over Time.(Brief Article)
January 15, 2002... 2002 JAN 15 - (NewsRx.com & NewsRx.net) -- Long-term breast cancer survivors report excellent quality of life many years after treatment, but the use of chemotherapy and tamoxifen in addition to surgery may result in decreased physical...

Complement Activation May Mediate Rituximab Complications.(Brief Article)
January 15, 2002... 2002 JAN 15 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States and Europe may have found the culprit behind inflammatory rituximab-induced complications seen in non-Hodgkin lymphoma...

Cascade Of Events Needed For p53 To Suppress Tumors.(Brief Article)
January 15, 2002... 2002 JAN 15 - (NewsRx.com & NewsRx.net) -- The innocuously named protein p53 is among the most vital of molecules for regulating cell growth in the human body, and it represents one of the body's leading defenses against the uncontrolled growth...

Researchers Seek To Block Tumor Growth By Interfering With Polyamines.(Brief Article)
January 15, 2002... 2002 JAN 15 - (NewsRx.com & NewsRx.net) -- Researchers have identified in the laboratory a promising new target for cancer chemotherapy that could impact tumor formation and metastasis by inhibiting cell growth. The study was performed by...

Glutathione Analogue Limits Tumor Vascularization In Murine Model.(Brief Article)
January 15, 2002... 2002 JAN 15 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A recent report issued by investigators in Italy indicates the glutathione analogue N-acetyl-L-cysteine (NAC) can inhibit vascularization in Kaposi sarcoma....

Lycopene, Antioxidant In Tomatoes, May Reduce Risk.(Brief Article)
January 15, 2002... 2002 JAN 15 - (NewsRx.com & NewsRx.net) -- The adage "an apple a day keeps the doctor away" may be facing stiff competition from tomatoes. Recent research at the University of Illinois at Chicago suggests that lycopene, an antioxidant...

Doppler Images Of Arteries Provide Useful Assessment For Breast Status.(Brief Article)
January 15, 2002... 2002 JAN 15 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A new study of women with breast cancer has revealed ultrasound images of arteries leading to the breast may provide useful diagnostic information. After...

Allos Therapeutics Names President and Chief Executive Officer.(Brief Article)
January 15, 2002... 2002 JAN 15 - (NewsRx.com & NewsRx.net) -- Allos Therapeutics, Inc., (ALTH) has appointed Michael E. Hart president and chief executive officer of the company. Hart has served as senior vice president, operations and chief financial...

Hamilton Jordan Named to Proxima Therapeutics Board of Directors.(Brief Article)
January 15, 2002... 2002 JAN 15 - (NewsRx.com & NewsRx.net) -- Proxima Therapeutics, Inc., a privately held developer and maker of accelerated cancer treatments using internal radiation therapy, has appointed Hamilton Jordan to its board of directors. ...

Sequential Use Of Doxorubicin And Docetaxel Produce High Pathologic Response Rate.(Brief Article)
January 15, 2002... 2002 JAN 15 - (NewsRx.com & NewsRx.net) -- Researchers at H. Lee Moffitt Cancer Center and Research Institute have found that dose-dense sequential administration of neoadjuvant docetaxel (Taxotere) and doxorubicin (Adriamycin) produced a 24%...

CTI Sponsors Clinical Study Using Thermal Imaging System.(Brief Article)
January 15, 2002... 2002 JAN 15 - (NewsRx.com & NewsRx.net) -- Radiologists at McKay-Dee Hospital Center in Ogden, Utah, are launching a study they anticipate will lead to more age-specific information about the detection of breast cancer using thermal imaging,...

Mayo Clinic Receives Patents From Procter & Gamble to Develop Drug Delivery Vehicle.(Brief Article)
January 15, 2002... 2002 JAN 15 - (NewsRx.com & NewsRx.net) -- Procter & Gamble (PG) has donated its patented colonic delivery technology to the Mayo Clinic, which is now better positioned to develop a new type of capsule that shows promise in more effectively...

Melanoma Web Sites Give Incomplete, Wrong Information, Study Says.(Brief Article)
January 15, 2002... 2002 JAN 15 - (NewsRx.com & NewsRx.net) -- Popular Internet sites devoted to melanoma may seem trustworthy, but the information they provide is often only skin-deep, a new University of Michigan study finds. In fact, the majority of sites...

MethylGene and ChemBridge Sign Research Agreement.(Brief Article)
January 15, 2002... 2002 JAN 15 - (NewsRx.com & NewsRx.net) -- MethylGene, Inc., and ChemBridge Research Laboratories, LLC (CRL) have signed a collaborative research and license agreement to design and develop small-molecule inhibitors against mutually selected...

Clinical Phase II Compound Gets Orphan Drug Status in U.S.(Brief Article)
January 15, 2002... 2002 JAN 15 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation for GPC Biotech's Phase II clinical compound Bryostatin-1 in combination with Taxol for the treatment of esophageal...

General Accounting Office Probes Tainted Medical Research.(Brief Article)
January 15, 2002... 2002 JAN 15 - (NewsRx.com & NewsRx.net) -- Universities and federal health officials must do more to prevent financial conflicts that could taint biomedical research and harm human subjects, a congressional review says. The study by the...

Mast Cells Implicated In Esophageal Carcinoma Angiogenesis.(Brief Article)
January 15, 2002... 2002 JAN 15 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Scientists have labeled tumor angiogenesis as a reliable marker for esophageal carcinoma. After assessing tumor specimens from over 50 individuals with...

Clinical Data From Phase I/II GVAX Vaccine Trial Updated.(Brief Article)
January 15, 2002... 2002 JAN 15 - (NewsRx.com & NewsRx.net) -- Cell Genesys, Inc., reported further clinical data from its multicenter Phase I/II GVAX lung cancer vaccine trial that demonstrated a complete tumor response rate of 12% and a median response duration...

Tumor Size A Surgical Guide For Some But Not All Non-Small Cell Cancers.(Brief Article)
January 15, 2002... 2002 JAN 15 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Surgeons can use tumor size as a guide for whether limited surgical intervention is needed in some but not all non-small cell lung cancers. In addition, a key...

Oxaliplatin-Based Chemotherapy Safe, Effective.(Brief Article)
January 15, 2002... 2002 JAN 15 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A chemotherapy regimen based on oxaliplatin can help patients suffering from high-risk non-Hodgkin's lymphoma, according to researchers in the United Kingdom....

AstraZeneca Submits Supplemental NDA for Bicalutamide 150 mg.(Brief Article)
January 15, 2002... 2002 JAN 15 - (NewsRx.com & NewsRx.net) -- AstraZeneca (AZN) has filed a Supplemental New Drug Application (sNDA) with the U.S. Food and Drug Administration (FDA) for its oral, once-daily hormonal medication Casodex (bicalutamide) for the...

CG7870 Shows Synergistic Antitumor Activity With Chemotherapy.(Brief Article)
January 15, 2002... 2002 JAN 15 - (NewsRx.com & NewsRx.net) -- Cell Genesys, Inc., reported further results of a Phase I/II clinical trial of CG7870, an oncolytic virus engineered to target and destroy prostate cancer cells which is being evaluated in patients...

Myriad Genetics Submits Clinical Trial for Flurizan to FDA.(Brief Article)
January 15, 2002... 2002 JAN 15 - (NewsRx.com & NewsRx.net) -- Myriad Genetics, Inc., (MYGN) has submitted a large, multicenter, double-blind, placebo-controlled human clinical trial of its prostate cancer drug, Flurizan (MPC-7869), to the U.S. Food and Drug...